Prodrugs of STAT3 inhibitors
US12043640B2 · kind B2 · utility
0Cited by
12References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2023 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65744
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein, in certain embodiments, are compounds of Formula I. or a pharmaceutically acceptable salt or a solvate thereof, compositions comprising a compounds of Formula I, or a pharmaceutically acceptable salt or a solvate thereof, and uses thereof such as in treating certain diseases or disorders (e.g., cancer, fibrosis, chronic inflammation).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.